Case Series of Crohn's Disease Patients Refractory to Anti-TNF Alpha Therapy on Uztekinumab

被引:0
|
作者
Siddiqui, Mohammad [1 ]
Shaikh, Amna [1 ]
Iqbal, Umair [2 ]
Schairer, Jason [1 ]
Kaur, Nirmal [3 ]
机构
[1] Henry Ford Hosp, Detroit, MI 48202 USA
[2] Bassett Med Ctr, Cooperstown, NY USA
[3] Henry Ford Hlth Syst, Novi, MI USA
来源
关键词
D O I
10.14309/00000434-201710001-02720
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2719
引用
收藏
页码:S1477 / S1477
页数:1
相关论文
共 50 条
  • [21] A SERIES OF GENES AS CANDIDATES PREDICTING RESPONSE TO ANTI-TNFα THERAPY IN CROHN DISEASE
    Nie Kai
    Wang Xiaoyan
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S469 - S470
  • [22] Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn's disease
    Gonzalez, H. Aleman
    Stamp, K.
    Whitehead, E.
    Pattinson, A.
    Turnbull, J.
    Myers, S.
    Talbot, A.
    Sebastian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I374 - I375
  • [23] Effect of anti-TNFα therapy with daily physical activity in patients with Crohn's disease
    Lucca, F. A.
    Malaguti, C.
    Cabalzar, A. L.
    Chebli, L. A.
    Ribeiro, T. C. R.
    Gaburri, P. D.
    Chebli, J. M. F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S344 - S344
  • [24] ACCELERATED DOSING SCHEDULE WITH USTEKINUMAB IN ANTI-TNF REFRACTORY CROHN'S DISEASE
    Gonzalez, Haidee Aleman
    Stamp, Katie
    Whitehead, Emma
    Myers, Sally
    Turnbull, Jack
    Pattinson, Alison
    Talbot, Alison
    Sebastian, Shaji
    [J]. GUT, 2021, 70 : A98 - A98
  • [25] Concomitant therapy with methotrexate and anti-TNF-a in pediatric patients with refractory crohn's colitis: A case series
    Absah, Imad
    Faubion, William A., Jr.
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (08) : 1488 - 1492
  • [26] Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn's disease
    Gonzalez, H. Aleman
    Stamp, K.
    Whitehead, E.
    Pattinson, A.
    Turnbull, J.
    Myers, S.
    Talbot, A.
    Sebastian, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I374 - I375
  • [27] The role of pharmacogenomics in the prediction of efficacy of anti-TNF therapy in patients with Crohn's disease
    Mascheretti, S
    Schreiber, S
    [J]. PHARMACOGENOMICS, 2004, 5 (05) : 479 - 486
  • [28] Identification of inflammatory mediators in patients with Crohn's disease unresponsive to anti-TNFα therapy
    Franco Leal, Raquel
    Planell, Nuria
    Kajekar, Radhika
    Lozano, Juan J.
    Ordas, Ingrid
    Dotti, Isabella
    Esteller, Miriam
    Carme Masamunt, M.
    Parmar, Harsukh
    Ricart, Elena
    Panes, Julian
    Salas, Azucena
    [J]. GUT, 2015, 64 (02) : 233 - 242
  • [29] Anti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease
    Aggarwal, Divya
    Limdi, Jimmy K.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (01) : 13 - 19
  • [30] WEIGHT ADJUSTED ANTI-TNF THERAPY FAVOURS OBESE PATIENTS WITH CROHN'S DISEASE
    Bhalme, M.
    Sharma, A.
    Keld, R.
    Makin, A.
    Willert, R.
    Campbell, S.
    [J]. GUT, 2012, 61 : A228 - A228